Objectives Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is a systemic autoimmune disease where infections ...

Allspring Premier Large Company Growth Fund lagged its benchmark in Q4 2025 but posted strong yearly gains. Read the full ...

ICU Medical (NASDAQ:ICUI) reported fourth-quarter 2025 revenue of $536 million and said it delivered 2% organic growth in the period and 5% organic growth for the full year, as management pointed to ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that the last ...

The Allspring Large Cap Growth Fund underperformed the Russell 1000 Growth Index during the fourth quarter. Read more here.

Evan Coleman is an Updates Editor on the Credit Cards and Travel Rewards team at Forbes Advisor, showcasing his interest in personal finance and love of travel. He has written for a variety of local ...

ICU Medical Inc (ICUI) reports strong Q4 revenue and gross margins, while addressing integration hurdles and tariff impacts.

SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial ...

The Pound US Dollar (GBP/USD) exchange rate traded with modest support on Monday as confusion surrounding US trade policy took its toll on the ‘Greenback’. Latest — Exchange Rates:Pound to Dollar (GBP ...

ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results ...

The Bank of England’s Monetary Policy Committee (MPC) voted to hold interest rates in February at 3.75%. It follows a cut in December 2025 from 4%. The next interest rate decision is scheduled for 19 ...

Advances in our understanding of the pathogenesis of rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus have led to the emergence of immunoglobulin-based therapy as a ...